WEKO3
アイテム
{"_buckets": {"deposit": "095fceda-64a1-4ed8-a99e-085636d62dc4"}, "_deposit": {"created_by": 1, "id": "75865", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "75865"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00075865", "sets": ["1"]}, "author_link": ["774997", "774991", "774996", "774999", "774986", "774983", "775004", "775003", "775001", "774995", "775002", "775005", "774985", "774994", "775000", "774993", "774984", "774992", "774982", "774990", "774987", "774998", "774988", "774989"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2019-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "9", "bibliographicPageEnd": "1150", "bibliographicPageStart": "1143", "bibliographicVolumeNumber": "24", "bibliographic_titles": [{"bibliographic_title": "International journal of clinical oncology"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Background: The efficacy of carbon-ion radiotherapy (C-ion RT) for lymph node (LN) oligo-recurrence has only been evaluated in limited single-center studies. We aimed to investigate the benefit of C-ion RT for LN oligo-recurrence in a large\nmulti-center study.\nMethods: Patients who received C-ion RT between December 1996 and December 2015 at 4 participating facilities and who met the following eligibility criteria were included: (i) histological or clinical diagnosis of LN recurrence; (ii) controlled primary\nlesion; (iii) no recurrence other than LN; (iv) LN recurrence involved in a single lymphatic site; and (v) age ≥ 20 years.\nResults: A total of 323 patients were enrolled. Median follow-up period was 34 months for surviving patients. The most common dose fractionation of C-ion RT was 48.0 Gy (relative biological effectiveness) in 12 fractions. Forty-seven patients\nhad a history of RT at the recurrent site. The 2-year local control (LC) and overall survival (OS) rates after C-ion RT were 85% and 63%, respectively. Only 1 patient developed grade-3 toxicity. Factors such as LN diameter, histology, and history of\nprevious RT did not correlate with LC. Smaller diameters (\u003c 30 mm) and numbers (≤ 3) of LN metastases as well as longer disease-free intervals post-primary therapy (≥ 16 months) were associated with significantly better OS.\nConclusions: C-ion RT for LN oligo-recurrence appeared to be effective and safe. C-ion RT may provide a survival benefit to patients with LN oligo-recurrence, particularly to those with few LN metastases, smaller LN diameters, and longer disease-free intervals.", "subitem_description_type": "Abstract"}]}, "item_8_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Springer-Verlag Tokyo"}]}, "item_8_relation_13": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "30968270", "subitem_relation_type_select": "PMID"}}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1007/s10147-019-01440-y", "subitem_relation_type_select": "DOI"}}]}, "item_8_relation_17": {"attribute_name": "関連サイト", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "https://link.springer.com/article/10.1007%2Fs10147-019-01440-y", "subitem_relation_type_select": "URI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1341-9625", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Okonogi, Noriyuki"}], "nameIdentifiers": [{"nameIdentifier": "774982", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kaminuma, Takuya"}], "nameIdentifiers": [{"nameIdentifier": "774983", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okimoto, Tomoaki"}], "nameIdentifiers": [{"nameIdentifier": "774984", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shinoto, Makoto"}], "nameIdentifiers": [{"nameIdentifier": "774985", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamamoto, Naoyoshi"}], "nameIdentifiers": [{"nameIdentifier": "774986", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamada, Shigeru"}], "nameIdentifiers": [{"nameIdentifier": "774987", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Murata, Kazutoshi"}], "nameIdentifiers": [{"nameIdentifier": "774988", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ohno, Tatsuya"}], "nameIdentifiers": [{"nameIdentifier": "774989", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shioyama, Yoshiyuki"}], "nameIdentifiers": [{"nameIdentifier": "774990", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsuji, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "774991", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakano, Takashi"}], "nameIdentifiers": [{"nameIdentifier": "774992", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kamada, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "774993", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okonogi, Noriyuki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "774994", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kaminuma, Takuya", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "774995", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okimoto, Tomoaki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "774996", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shinoto, Makoto", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "774997", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamamoto, Naoyoshi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "774998", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamada, Shigeru", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "774999", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Murata, Kazutoshi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "775000", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ohno, Tatsuya", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "775001", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shioyama, Yoshiyuki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "775002", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsuji, Hiroshi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "775003", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakano, Takashi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "775004", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kamada, Tadashi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "775005", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS)."}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/75865", "pubdate": {"attribute_name": "公開日", "attribute_value": "2019-05-21"}, "publish_date": "2019-05-21", "publish_status": "0", "recid": "75865", "relation": {}, "relation_version_is_last": true, "title": ["Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS)."], "weko_shared_id": -1}
Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).
https://repo.qst.go.jp/records/75865
https://repo.qst.go.jp/records/758657cc572c6-f54b-4604-a9a8-cb7b7e9e5345
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2019-05-21 | |||||
タイトル | ||||||
タイトル | Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS). | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Okonogi, Noriyuki
× Okonogi, Noriyuki× Kaminuma, Takuya× Okimoto, Tomoaki× Shinoto, Makoto× Yamamoto, Naoyoshi× Yamada, Shigeru× Murata, Kazutoshi× Ohno, Tatsuya× Shioyama, Yoshiyuki× Tsuji, Hiroshi× Nakano, Takashi× Kamada, Tadashi× Okonogi, Noriyuki× Kaminuma, Takuya× Okimoto, Tomoaki× Shinoto, Makoto× Yamamoto, Naoyoshi× Yamada, Shigeru× Murata, Kazutoshi× Ohno, Tatsuya× Shioyama, Yoshiyuki× Tsuji, Hiroshi× Nakano, Takashi× Kamada, Tadashi |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Background: The efficacy of carbon-ion radiotherapy (C-ion RT) for lymph node (LN) oligo-recurrence has only been evaluated in limited single-center studies. We aimed to investigate the benefit of C-ion RT for LN oligo-recurrence in a large multi-center study. Methods: Patients who received C-ion RT between December 1996 and December 2015 at 4 participating facilities and who met the following eligibility criteria were included: (i) histological or clinical diagnosis of LN recurrence; (ii) controlled primary lesion; (iii) no recurrence other than LN; (iv) LN recurrence involved in a single lymphatic site; and (v) age ≥ 20 years. Results: A total of 323 patients were enrolled. Median follow-up period was 34 months for surviving patients. The most common dose fractionation of C-ion RT was 48.0 Gy (relative biological effectiveness) in 12 fractions. Forty-seven patients had a history of RT at the recurrent site. The 2-year local control (LC) and overall survival (OS) rates after C-ion RT were 85% and 63%, respectively. Only 1 patient developed grade-3 toxicity. Factors such as LN diameter, histology, and history of previous RT did not correlate with LC. Smaller diameters (< 30 mm) and numbers (≤ 3) of LN metastases as well as longer disease-free intervals post-primary therapy (≥ 16 months) were associated with significantly better OS. Conclusions: C-ion RT for LN oligo-recurrence appeared to be effective and safe. C-ion RT may provide a survival benefit to patients with LN oligo-recurrence, particularly to those with few LN metastases, smaller LN diameters, and longer disease-free intervals. |
|||||
書誌情報 |
International journal of clinical oncology 巻 24, 号 9, p. 1143-1150, 発行日 2019-01 |
|||||
出版者 | ||||||
出版者 | Springer-Verlag Tokyo | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1341-9625 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 30968270 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1007/s10147-019-01440-y | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | https://link.springer.com/article/10.1007%2Fs10147-019-01440-y |